DOCSLIB.ORG

Pelvic Radioiodine Uptake in a Rectal Wall Teratoma After Thyroidectomy for Papillary Carcinoma

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Pelvic Radioiodine Uptake in a Rectal Wall Teratoma After Thyroidectomy for Papillary Carcinoma Pelvic Radioiodine Uptake in a Rectal Wall Teratoma After Thyroidectomy for Papillary Carcinoma Mark Lakshmanan*, James C. Reynolds, Silvana Del Vecchio, Maria J. Memo, Jeffrey A. Norton, and Jacob Robbins Clinical Endocrinology Branch, National Institute ofDiabetes and Digestive and Kidney Diseases, NIH; Nuclear Medicine Department, Warren Grant Magnuson Clinical Center, NIH; Laboratory ofPazhology and Surgery Branch, National Cancer Institute, NIH, Bethesda, Maryland; and Istituto Medicina Nucleare, II Facolta Di Med. E. Chir., Naples, Italy CLINICAL PRESENTATION A 30-yr-oldwoman with previouslyresected papillarythyroid A 30-yr-oldwoman developeda sorethroat, a painfulthyroid carcinoma was found to have a pelvic lesion which concen nodule and slight hoarseness. A [@mTc]pertechnetatescan showed trated radloiodine. By performing simultaneous 1311whole decreased activity in the lower pole ofthe right lobe ofthe thyroid body and @“Tc-methylenediphosphonate bone scans, we that corresponded to the 2-cm nodule. A fine needle aspirate found the lesion to be in soft tissue between the sacrum and showedpapillarycarcinoma.Alsopalpablewerea 5-mm nodule bladder. Rad@iodine therapy was postponed so that the in the left lobe and a 1-cm movable lymph node in the left lesion, a benign teratoma of the rectal wall, could be surgically posterior cervical chain. removed. Prior to laparotomy, the patient received a second At total thyroidectomy,the right lobe contained a calcified tracer dose of 1311so that the lesion could be located at masswith a proliferationof follicleslined by cuboidalcellswith surgery with a hand-held gamma detector. A postoperative characteristic clear nuclei and occasional papillary formation. whole-body 1311scan confirmed that the lesion had been Elsewhere,the gland contained multiple small tumor foci of removed, thus reducing the absorbed radiation that would similar histology. The diagnosis was multi-focal papillary thyroid have been received by the ovaries during radioiodine therapy. carcinoma,follicularvariant. The nodule in the left lobe was a Althoughthe lesioncontainedboththyroidandgastricepithe follicular adenoma. hum, accumulated 131Iwas limited to the area with thyroid A whole-bodyscan(1.5mCi ‘@‘I),6 wkafter surgeryand 2 wk follicles. after discontinuing triiodothyronine, showed left thyroid bed J NucI Med 1992; 33:1848—1850 activity and another focus in the pelvisjust to the right of midline (Fig lA). Because images 48 hr later and following a cathartic showedthe pelvic focus again, combined 99mTc..MDpand 1311 scanswereobtainedwhichshowedthat the 1311focuswasin soft tissue,anterior to the sacrum and cephaladto the bladder (Fig his report describes a patient with papillary thyroid 1B). Diagnostic considerations included a lymph node metastasis cancer whose initial ‘@‘Iscan after thyroid surgery showed of thyroid carcinoma, Meckel's diverticulum (1), an ovarian a focus ofactivity in the pelvis. Combined ‘@‘Iand @mTc@teratoma (2—4)and an ovarian cystadenoma (5). She had no methylene diphosphonate (MDP) scanning, and intra-op urinary, gynecologic or gastrointestinal symptoms. Pelvic and erative use of a hand-held gamma detector aided in beat barium enema examinations were normal. Ultrasound showed a prominentrightovarywithsmallcysticareas.There wasfluidin ing the lesion in the rectal wall. The lesion concentrated the pelvis. 0. 105% of the administered radioiodine and proved to be A repeatwhole-bodyscan 2 mo later again showedthe pelvic a benign teratoma. Its resection before ‘@Itherapy pre focus. T3 replacement was restarted and the next day a laparot vented excess radiation to the ovaries. omy was performed. A 3-cm cystic mass adherent to the wall of the proximal rectum was identified. A hand-held gamma detector showedthat the masswasintenselyradioactiveand when it was resected the pelvic counts dropped to background. ReCeiVedNov. 6, 1991 ; revision accepted Jun. 2, 1992. The cyst,containingthick creamy fluidand a central massof For reprints contact: Dr. Jacob Robbins, CEB/NIDDK, NIH, 9000 Rockville firm tan tissue, measured 3.2 x 1.4 x 1.3 cm and weighed 2.8 g. Pike, Bethesda, MD 20892. Squamous, transitional and respiratory epithelium lined the cyst . Currentaddress: Departmentsof Medidne and Physiology and Biophysics, School of Medicine, CWRU. wall (Fig. 2). The solid nodule contained gastric and colonic Disclaimer:The opinionsor assertions of this publicationare the private epithelium, skin appendages, smooth muscle, lymphoid aggre views of the authors and are not to be construed as official or reflecting the @ viewsofthe U.S.Government,nordoes mentionoftrade names commercial gates, fibrovascular connective tissue and cartilage. Glandular products ui@plyendorsement by the U.S. Government. structures resembling follicular thyroid epithelium were adjacent 1848 The Journal of Nuclear Medicine•Vol.33 •No. 10 •October1992 1A lB 4,' Iw 4. @ @,,. ., @,.‘ @ i-,. ‘.‘, FIGURE 1. (A)Posteriorwhole-body1311scan after thyroidec @ tomy. Besides physiological uptake in the bladder, radioiodine ‘v: @• concentration was present just to the right of the midline in the pelvis (arrow). Iodine-I31 was also present in the left thyroid bed (not shown). The foci along the right leg are 1@Bareference standards.(B)Imagesof the posteriorpeMs (upperpanels),right ) @4L@ lateral peMs (middle panels), and with the patient sitting above the camera (lower panels). On the left are the @rc-MDPbone 4v4@,, @. scans; on the rightare overlaysof the bone and 1311scans. The arrowspointtothelesionaccumulating1311. to mucus secreting glands and respiratory epithelium. The diag FIGURE 2. (A) Highpowerviewof the pelviclesion,demon nosis was benign cystic teratoma of the colon. stratingmaturetissuefromthegermlayersincludinggastrictype After the laparotomy, gamma camera images of the pelvis epithelium(H&E,200x).(B)HighpowerviewofthepeMclesion showed that the focus of radioiodine had disappeared. Later, a showing glandular structures resembling thyroid follicles and the 30 mCi ‘@‘itreatment was givento ablate the thyroid remnant; cyst walllinedby maturerespiratoryepithelium(H&E,200x). at 96 hr gamma camera imagesagain showedthe thyroid bed activity, but pelvic activity was normal. areas contained eosinophilic epithelium (Fig. 3). Although the Iodlne-131AssayandQuantftativeAutoradiography 20-sm autoradiographic sections were too thick for precise iden Radioactivitywasmeasuredin a gamma wellcounter and its tification ofcell type, the areas containing radioactivity coincided distribution determined by quantitative autoradiography (6). with anti-thyroglobulin antibody-stained small thyroid follicles Dried frozen sections,20 @mthick, were used to exposex-ray and not with adjacent gastric-like epithelium. film that was later analyzed with a scanning microdensitometer. Adjacentsectionswerestainedwith hematoxylinand eosin. The lesion contained 0.105% of the administered ‘@‘iwith 0.01%ofthis in the cystfluidand wall.Correctedfordecay,solid DISCUSSION tissue contained 1.5 @iCior 3.73 @iCi/g.A comparison of H & E In adults, the ovary is the most common location of and autoradiographicsectionsshowedthat the most radioactive teratomas, although retroperitoneal organs are also com A B FIGURE 3. Autoradiograph(A)of a 20- @msection (B) of the pelvic lesion dam C onstratingthe presence of 1311in a limited area. Thiscoincideswith the regionthat contaned thyroid follicles and not with other regionsthat were richingastric epi thelium. Radioiodine in Rectal Wall Teratoma •Lakshmanan et al 1849 mon sites (7-9). These tumors may arise in the rectum or REFERENCES colon (10—15)or secondarily involve lower bowel that is 1. Caplan RH, Gunderson GA, Abellera RM, et al. Uptake ofiodine-131 by adjacent to a primary tumor in the ovary (16—19)or the a Meckel'sdiverticulummimickingmetastaticthyroid cancer. C/in Nuc/ fallopian tube (20). Almost all are benign. About 10% of Med 1987;12:760—762. 2. Yeh E-L, Meade RC, Ruetz PP. Radionuclidestudy of struma ovarii.J benign cystic teratomas of the ovary contain mature thy Nuc/Med 1973;14:1l8—121. roid tissue (21,22). The frequency ofthyroid tissue occur 3. FalsettiL,SchivardiMR. MairaG, etal.Riscontrodistrumaovariiinuna paziente in trattamento per carcinoma tiroideo. Ann os: Gin Med Penn ring in cobonic teratomas is unknown. 1985;106:290—293. In the present case, a benign cystic teratoma of the 4. ZwasST, HeymanZ, LiebermanLM. ‘@‘Iovarianuptakein a whole-body rectosigmoid colon was detected by ‘@‘Iwhole-body scan scan for thyroidcarcinoma.SeminNuc/Med l989;19:340—342. 5. Kim EE, Pjura G, Gobuty A, et al. 1-131uptake in benignserouscystade ning. First, a solitary pelvic bone metastasis was excluded noma ofthe ovary.EunJ Nuc/Med 1984;9:433—435. by simultaneous ‘@‘Iwhole-body and @Tc-MDPbone 6. Del Vecchio S, Reynolds JC, Blasberg RG, et al. Measurement oflocal Mr scans. From the results of these studies, the most likely 97,000 and 250,000 protein antigen concentration in sections of human melanomatumor usingin vitroquantitativeautoradiography.CancenRes lesion was a Meckel's diverticulum or an ovarian teratoma, l988;48:5475—5481. a pelvic lymph node metastasis being less likely. Rather 7. Pack GT, Tabab EJ. Primary retroperitoneal tumors: a study of 120 cases. than immediate ‘@‘Itherapy, exploratory surgery was un SungGyneco/Obste:Ini/Absi Sungl954;99:209—23land313—341. 8. EngelRM, ElkinsRC,FletcherBD.Retroperitonealteratoma,reviewof dertaken to remove a potentially
Load more

Recommended publications
  • Thyroid Follicular Adenoma: Benign Or Malignant?
    Volume 4 Number 3 Medical Journal of the ['ayiz1369 Islamic Repuhlit of Imn Rabiolawwal141 I F:llll990 THYROID FOLLICULAR ADENOMA: BENIGN OR MALIGNANT? HOSSEIN GHARIB, M.D. From fhe Division of Endocrillology and !lIlernal Medicine, Mayo Clinic and Mayo FOll1uiafion, Rochester, MillllCSOla, U.S.A. ABSTRACT Four patients are described in whom a follicular carcinoma developed following thyroidectomy for a benign follicular neoplasm. It is possible that the initial thyroid neoplasm was a well- differentiated follicular carcinoma which was microscopically indistinguishable from a benign adenoma. Realizing this pathologic pitfall in thyroid diagnosis, the need for meticulous examination of the pathologic specimen is emphasized. Long- term postop­ erative reassessment is recommended. MIIRI, Vol. 4, No.3, 173-176, 1990 INTRODUCTION CASE REPORTS Follicular adenoma is the most common type of Case I cellular thyroid adenomas. 1 There is considerable de­ A 49-year-old woman was referred for evaluation of bate whether follicular adenoma of the thyroid, a metastatic thyroid carcinoma. She was in good health benign neoplasm, is a precancerous lesion which occa­ until six months earlier when she complained of ins om- sionally may be mistaken for a carcinoma2.30n the nia and nervousness. Two months before admission a other hand, several published reports indicate that a routine chest x-ray revealed metastatic nodules in both follicular adenoma which appears benign by conven­ lungs. Extensive laboratory tests and radiographic tional histologic criteria, may demonstrate malignant studies were negative. A diagnostic left thoracotomy behavior."·() showed ,dow grade thyroid cancep. and she was refer­ This report describes four patients whose thyroid red for further examination.
    [Show full text]
  • Comprehensive Assessment of TERT Mrna Expression Across a Large Cohort of Benign and Malignant Thyroid Tumours
    cancers Article Comprehensive Assessment of TERT mRNA Expression across a Large Cohort of Benign and Malignant Thyroid Tumours Ana Pestana 1,2,3, Rui Batista 1,2,3, Ricardo Celestino 1,2,3,4 , Sule Canberk 1,2,5, Manuel Sobrinho-Simões 1,2,3,6 and Paula Soares 1,2,3,7,* 1 Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), 4200-135 Porto, Portugal; [email protected] (A.P.); [email protected] (R.B.); [email protected] (R.C.); [email protected] (S.C.); [email protected] (M.S.-S.) 2 i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal 3 Medical Faculty of University of Porto (FMUP), 4200-139 Porto, Portugal 4 School of Allied Health Technologies, Polytechnic of Porto, 4200-072 Porto, Portugal 5 Abel Salazar Biomedical Sciences Institute (ICBAS), University of Porto, 4050-313 Porto, Portugal 6 Department of Pathology, Centro Hospitalar São João, 4200-139 Porto, Portugal 7 Department of Pathology, Medical Faculty of the University of Porto, 4200-139 Porto, Portugal * Correspondence: [email protected]; Tel.: +351-220-408-800 Received: 10 June 2020; Accepted: 6 July 2020; Published: 9 July 2020 Abstract: The presence of TERT promoter (TERTp) mutations in thyroid cancer have been associated with worse prognosis features, whereas the extent and meaning of the expression and activation of TERT in thyroid tumours is still largely unknown. We analysed frozen samples from a series of benign and malignant thyroid tumours, displaying non-aggressive features and low mutational burden in order to evaluate the presence of TERTp mutations and TERT mRNA expression in these settings.
    [Show full text]
  • Genetic Landscape of Papillary Thyroid Carcinoma and Nuclear Architecture: an Overview Comparing Pediatric and Adult Populations
    cancers Review Genetic Landscape of Papillary Thyroid Carcinoma and Nuclear Architecture: An Overview Comparing Pediatric and Adult Populations 1, 2, 2 3 Aline Rangel-Pozzo y, Luiza Sisdelli y, Maria Isabel V. Cordioli , Fernanda Vaisman , Paola Caria 4,*, Sabine Mai 1,* and Janete M. Cerutti 2 1 Cell Biology, Research Institute of Oncology and Hematology, University of Manitoba, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada; [email protected] 2 Genetic Bases of Thyroid Tumors Laboratory, Division of Genetics, Department of Morphology and Genetics, Universidade Federal de São Paulo/EPM, São Paulo, SP 04039-032, Brazil; [email protected] (L.S.); [email protected] (M.I.V.C.); [email protected] (J.M.C.) 3 Instituto Nacional do Câncer, Rio de Janeiro, RJ 22451-000, Brazil; [email protected] 4 Department of Biomedical Sciences, University of Cagliari, 09042 Cagliari, Italy * Correspondence: [email protected] (P.C.); [email protected] (S.M.); Tel.: +1-204-787-2135 (S.M.) These authors contributed equally to this paper. y Received: 29 September 2020; Accepted: 26 October 2020; Published: 27 October 2020 Simple Summary: Papillary thyroid carcinoma (PTC) represents 80–90% of all differentiated thyroid carcinomas. PTC has a high rate of gene fusions and mutations, which can influence clinical and biological behavior in both children and adults. In this review, we focus on the comparison between pediatric and adult PTC, highlighting genetic alterations, telomere-related genomic instability and changes in nuclear organization as novel biomarkers for thyroid cancers. Abstract: Thyroid cancer is a rare malignancy in the pediatric population that is highly associated with disease aggressiveness and advanced disease stages when compared to adult population.
    [Show full text]
  • A Marker to Distinguish Follicular Thyroid Adenoma from Carcinoma'
    [CANCERRESEARCH57.2144-2147. June I, 1997) Advances in Brief Telomerase Activity: A Marker to Distinguish Follicular Thyroid Adenoma from Carcinoma' Christopher B. Umbricht, Motoyasu Saji, William H. Westra, Robert Udelsman, Martha A. Zeiger, and Saraswati Sukumar@ Breast Cancer Program. Oncology Center (C. B. U., S. SI. Division of Surgical Oncology and Endocrine Surgery (M. S.. R. U., M. A. 1], and Department of Pathology 1W. H. WI, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 Abstract Finally, activation of one of the three ras oncogenes appears to be a fairly common and early event (5) but is detected in adenomas as well The inability to distinguish microinvasivefollicular thyroid cancer as in carcinomas. More importantly, less than 50% of follicular from benign follicular tumors preoperatively presents an important sur carcinomas in any published series show these changes (6, 7). Thus, gical dilemma. We examined 44 folilcular tumors and found telomerase no molecular markers that can reliably distinguish adenomas from activity in all 11 folllcular carcinomas and in S of 33 benign fofficular tumors. It was undetectable in 22 normal thyroid tissues adjacent to the carcinomas have yet been found. Recently, activation of the ribonu tumors. Telomerase activity may thus provide a diagnostic marker dis cleoprotein telomerase has been found in a wide variety of carcinomas tinguishing benign from malignant follicular thyroid tumors. The ability (8—li). Telomerase is an enzyme that maintains the stability and to identify invasive follicular thyroid tumors could avert over 14,000 integrity of chromosomal ends composed of telomeres (12). Although thyroidectomies annually in the United States, thereby significantly de telomerase activity is repressed in almost all nonneoplastic somatic creasing morbidity and health care costs.
    [Show full text]
  • Cancer Mortality in Women with Thyroid Disease1
    (CANCER RESEARCH 50. 228.1-2289. April 15. 1990| Cancer Mortality in Women with Thyroid Disease1 Marlene B. Goldman,2 Richard R. Monson, and 1aralio Maloof Department of Epidemiology, Harvard School of Public Health, Boston 02115 [M. B. 6"..R. K. M.J, and Thyroid I'nil, Massachusetts Ornerai Hospital, Boston 02114 /F. M.I, Massachusetts ABSTRACT in a study of American women (4). A mechanism for a causal relationship between the two diseases is not established, al A retrospective follow-up study of 7338 women with either nontoxic though thyroid hormones are known to influence the breast nodular goiter, thyroid adenoma, hyperthyroidism, hypothyroidism, Hashimoto's thyroiditis, or no thyroid disease was conducted. All women either directly or through effects on thyroid-stimulating hor patients at the Massachusetts General Hospital Thyroid Clinic who were mone, prolactin, estrogens, or androgens. Researchers sug seen between 1925 and 1974 and who were treated for a minimum of 1 gested that a deficit of thyroid hormone altered the hormonal year were traced. A total of 2231 women (30.4%) were dead and 2012 milieu in a way that permitted the growth of malignant cells (1, women (27.4%) were alive as of December 31, 1978. Partial follow-up 5, 6). It is just as reasonable to hypothesize, however, that an information was available for the remaining 3095 women (42.2%). The excess of thyroid hormone may promote tumor growth. A average length of follow-up was 15.2 years. When losses to follow-up number of biochemical and clinical studies have been con were withdrawn at the time of their loss, the standardized mortality ratios ducted, but no consensus has been reached as to the role of (SMR) for all causes of death were 1.2 |95% confidence interval (CI), thyroid hormones in the initiation or promotion of cancer.
    [Show full text]
  • Carotid Body Tumor Associated with Primary Hyperparathyroidism
    DOI: 10.30928/2527-2039e-20212755 _______________________________________________________________________________________Relato de caso CAROTID BODY TUMOR ASSOCIATED WITH PRIMARY HYPERPARATHYROIDISM TUMOR DO CORPO CAROTÍDEO ASSOCIADO COM HIPERPARATIREOIDISMO PRIMÁRIO Duilio Antonio Palacios1; Ledo Massoni1; Climério Pereira do Nascimento1; Marilia D'Elboux Brescia, TCBC-SP1; Sérgio Samir Arap, TCBC-SP1; Fabio Luiz de Menezes Montenegro, TCBC-SP1. ABSTRACT Introduction: Carotid body tumors (CBT) are an uncommon tumor of head and neck. The associa- tion between this entity with primary hyperparathyroidism (PHPT) is even rarer and few cases have been reported. Case Report: We described two cases of association between CBT and PHPT. The first case was a 55-year-old male patient with Shambling type III malignant paraganglioma and PHPT sin- gle adenoma. The second one was a 56-year-old male patient with Shambling type III paraganglioma and double parathyroid adenoma. Conclusion: The adequate preoperative evaluation allowed to iden- tify and treat simultaneously both neoplasms in these patients without compromising the appropriate treatment. Treatment of the two neoplasms when identified could be performed satisfactorily at the same surgical time. Keywords: Carotid Body Tumor. Hyperparathyroidism. Hypercalcemia. Treatment Outcome. RESUMO Introdução: O paraganglioma de corpo carotídeo (PCC) é um dos tumores menos frequente da cabeça e do pescoço. A associação entre essa entidade e o hiperparatireoidismo primário (HPT) é ainda mais rara e poucos casos foram relatados. Relato do Caso: Relatam-se dois novos casos de PCC e HPT. O primeiro é um paciente de 55 anos com um paraganglioma maligno que envolvia as artérias carótidas interna e externa (Shambling III) e um adenoma de paratireoide. O segundo trata-se de paciente mas- culino de 56 anos, também com tumor Shambling III, mas com duplo adenoma de paratireoide.
    [Show full text]
  • Using Deep Convolutional Neural Networks for Multi-Classification of Thyroid Tumor by Histopathology: a Large-Scale Pilot Study
    468 Original Article Page 1 of 13 Using deep convolutional neural networks for multi-classification of thyroid tumor by histopathology: a large-scale pilot study Yunjun Wang1,2#, Qing Guan1,2#, Iweng Lao2,3#, Li Wang4, Yi Wu1,2, Duanshu Li1,2, Qinghai Ji1,2, Yu Wang1,2, Yongxue Zhu1,2, Hongtao Lu4, Jun Xiang1,2 1Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China; 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China; 3Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China; 4Depertment of Computer Science and Engineering, Shanghai Jiao Tong University, Shanghai 200240, China Contributions: (I) Conception and design: J Xiang, H Lu, Y Zhu; (II) Administrative support: J Xiang, H Lu, D Li, Y Wu, Q Ji, Y Wang; (III) Provision of study materials or patients: I Lao, Q Guan, Y Wang; (IV) Collection and assembly of data: I Lao, Q Guan, Y Wang; (V) Data analysis and interpretation: L Wang, Y Wang; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. #These authors contributed equally to this work. Correspondence to: Jun Xiang, MD, PhD. Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China. Email: [email protected]; Hongtao Lu, PhD. Department of Computer Science and Engineering, Shanghai Jiao Tong University, Shanghai 200240, China. Email: [email protected]; Yongxue Zhu, MD. Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China. Email: [email protected]. Background: To explore whether deep convolutional neural networks (DCNNs) have the potential to improve diagnostic efficiency and increase the level of interobserver agreement in the classification of thyroid nodules in histopathological slides.
    [Show full text]
  • Chronic Iodine Deficiency As Cause of Neoplasia in Thyroid and Pituitary of Aged Rats
    203 CHRONIC IODINE DEFICIENCY AS CAUSE OF NEOPLASIA IN THYROID AND PITUITARY OF AGED RATS. F. BIELSCHOWSKY. From the, Hugh Adam Cancer Research Department of the Medical School and the New Zealand Branch of the British Empire Cancer Campaign, University of Otago, Dunedin. Received for publication April 7, 1953. JUDGING from the literature, adenomata occur more frequently in the pitu- itaries than in the thyroids of aged rats. At the routine autopsies of 154 albinos of the Wistar strain, 41 of which were males, 86 intact and 27 spayed females, 24 cases of adenoma of the pituitary were discovered. Seven of these occurred in the males, 16 in the intact females and only one in an ovariectomised animal. The average age of these rats was 2 years. Adenomata of the thyroid were found in 5 animals, 4 times in combination with neoplastic lesions of the pituitary. Post-mortem examinations performed on old rats of a more recently acquired hooded strain have furnished three additional cases of tumours of thyroid and pituitary. The paper describes the findings in these 8 rats, and endeavours to interpret the pathogenesis of the neoplastic lesions found in the two endocrine glands as a sequel to chronic iodine deficiency. MATERIALr AND METHODS. Like all our stock rats, the animals described in this paper were kept during their lifetime in a room separated from the experimental animals and had there- fore no contact with goitrogenic or carcinogenic agents. The diet consisted of a dry mixture of bran 30 per cent, pollard 35 per cent, meat meal 15 per cent, maize meal 15 per cent and bone flour 5 per cent, supplemented by wheat and kibbled maize, and once weekly by green vegetables and cod liver oil.
    [Show full text]
  • High Incidence of Extrapancreatic Neoplasms in Patients with Intraductal Papillary Mucinous Neoplasms
    ORIGINAL ARTICLE High Incidence of Extrapancreatic Neoplasms in Patients With Intraductal Papillary Mucinous Neoplasms Min-Gew Choi, MD; Sun-Whe Kim, MD; Sung-Sik Han, MD; Jin-Young Jang, MD; Yong-Hyun Park, MD Background: Intraductal papillary mucinous neo- (33%) and colorectal adenocarcinoma (17%) were the plasms (IPMNs) are associated with a high incidence of most common neoplasms in the 24 patients. During post- extrapancreatic neoplasms. operative follow-up, 3 patients died of malignant IPMNs, 3 of associated malignancies, and 1 of a nonmalignancy- Design: Retrospective study. related cause. Comparisons of the clinicopathological fea- tures in patients with IPMNs with and without associ- Setting: Tertiary care referral center. ated malignancies revealed no significant differences in age, sex, family history of malignancy, history of ciga- Patients: Sixty-one patients underwent surgical resec- rette smoking or alcohol abuse, or type of IPMN. The in- tion for IPMN between January 1, 1993, and June 30, cidence of extrapancreatic neoplasms in patients with 2004. Thirty-eight patients with mucinous cystic neo- IPMN was significantly higher than in those with other plasms and 50 patients with pancreatic ductal adenocar- pancreatic diseases such as mucinous cystic neoplasm cinoma also were examined for development of extra- (8%) or pancreatic ductal adenocarcinoma (10%). pancreatic neoplasms. Conclusions: Frequently, IPMNs are associated with the Main Outcome Measures: The incidence and clini- development of extrapancreatic neoplasms. Consider- copathological features of extrapancreatic neoplasms with able attention should be paid to the possible occurrence IPMNs were compared with those with mucinous cystic of other associated malignancies in patients with IPMNs, neoplasm and pancreatic ductal adenocarcinoma.
    [Show full text]
  • Selected Cases Steering Committee
    2019 24-27 October 2019 Regnum Carya Convention Center, Antalya - Turkey SELECTED CASES www.endobridge.org STEERING COMMITTEE E. Dale Abel President, ES Dolores Shoback Secretary-Treasurer, ES Andrea Giustina President, ESE Aart J Van Der Lely Immediate Past President, ESE Jens Bollerslev Immediate Past Chair, Education Committee, ESE Camilla Schalin-Jäntti Chair, Education Committee, ESE Fusun Saygili President, SEMT Sadi Gundogdu Past President, SEMT Bulent O. Yildiz Founder & President, EndoBridge® Dilek Yazici Scientific Secreteriat, EndoBridge® Ozlem Celik Scientific Secreteriat, EndoBridge® 2 24 - 27 October, 2019 Antalya - Turkey SCIENTIFICSCIENTIFIC PROGRAMME PROGRAM Friday, 25 October 2019 08.40-09.00 Welcome and Introduction to EndoBridge 2019 MAIN HALL 09.00-11.00 Chairs: Ahmet Sadi Gündoğdu, Füsun Saygılı 09.00-09.30 Modern ways to visualise pituitary tumors - Mark Gurnell 09.30-10.00 What is new in the diagnosis and management of acromegaly Sebastian Neggers 10.00-10.30 Treatment of Cushing disease when surgery fails: Individualized case- based approach - Misa Pfeifer 10.30-11.00 Radiotherapy for pituitary tumors - Michael Brada 11.00-11.20 Coffee Break 11.20-12.50 Interactive Case Discussion Sessions HALL A Pituitary - AJ Van Der Lely, Monica Marazuela HALL B Adrenal - Gary Hammer, Özlem Turhan İyidir HALL C Neuroendocrine tumors - Beata Kos - Kudla, Gregory Kaltsas HALL D Male Reproductive Endocrinology - Dimitrios Goulis, Pınar Kadıoğlu 12.50-14.00 Lunch 14.00-15.30 Interactive Case Discussion Sessions HALL A Pituitary
    [Show full text]
  • Incidence of Thyroid Neoplasm and Pancreatic Cancer In
    Redacted study protocol Incidence of Thyroid Neoplasm and Pancreatic Cancer in Type 2 Diabetes Mellitus Patients who Initiate Once Weekly Exenatide Compared with Other Antihyperglycemic Drugs Redacted protocol based on original protocol version 3 of August 14, 2013 LAY SUMMARY Many patients with diabetes mellitus, increased sugar levels, are treated with medicines. Different types of medicines are available. The present study is intended to monitor the occurrence of two types of cancer with weekly exenatide. Anonymised electronic health care records will be used to monitor the weekly exenatide users and compare them to patients using other types of medication. 1 BACKGROUND Diabetes mellitus is a major public health problem worldwide and especially in the United Kingdom (UK). According to Diabetes UK, approximately 2.8 million people in the UK had diabetes in 2010 [1]. Type 2 diabetes (T2DM) accounts for 90-95% of diagnosed cases of diabetes and is associated with older age, obesity, family history of diabetes, gestational diabetes, impaired glucose metabolism, physical inactivity. Diabetes is a leading cause of blindness, end-stage renal disease, non-traumatic lower limb amputation, and is a major risk factor for coronary artery disease and stroke [2]. Interventions that improve glycemic control reduce microvascular complications involving the eyes, kidneys and nerves, and may reduce macrovascular complications such as myocardial infarction [3]. Many of the traditional diabetes medications (such as sulfonylureas (SU), metformin, α-glucosidase inhibitors, thiazolidinediones (TZDs), and insulin) lower blood glucose, but they may also produce hypoglycemia, gastrointestinal symptoms, or weight gain. The American Diabetes Association recommends a hemoglobin A1C goal of less than 7%, but many diabetic patients are unable to achieve this goal by using oral drug combinations or diet and exercise.
    [Show full text]
  • The Elevated Serum Alkaline Phosphatase – the Chase That Led to Two Endocrinopathies and One Possible Unifying Diagnosis
    European Journal of Endocrinology (1999) 140 143–147 ISSN 0804-4643 CASE REPORT The elevated serum alkaline phosphatase – the chase that led to two endocrinopathies and one possible unifying diagnosis Hsu Li-Fern and Rajasoorya C Department of Medicine, Alexandra Hospital, Singapore (Correspondence should be addressed to Rajasoorya C, Department of Medicine, Alexandra Hospital, 378 Alexandra Road, Singapore 159964) Abstract A 39-year-old Chinese man with hypertension being evaluated for elevated serum alkaline phos- phatase (SAP) levels was found to have an incidental right adrenal mass. The radiological features were characteristic of a large adrenal myelolipoma. This mass was resected and the diagnosis confirmed pathologically. His blood pressure normalised after removal of the myelolipoma, suggesting that the frequently observed association between myelolipomas and hypertension may not be entirely coincidental. Persistent elevation of the SAP levels and the discovery of hyper- calcaemia after surgery led to further investigations which confirmed primary hyperparathyroidism due to a parathyroid adenoma. The patient’s serum biochemistry normalised after removal of the adenoma. The association of adrenal myelolipoma with primary hyperparathyroidism has been reported in the literature only once previously. Although unconfirmed by genetic studies this association may possibly represent an unusual variation of the multiple endocrine neoplasia type 1 syndrome. European Journal of Endocrinology 140 143–147 Introduction months, and had a history of hypertension since the age of 35 which was satisfactorily controlled with Nifedi- Myelolipomas of the adrenal gland are benign tumours pine. Investigations carried out at that time to exclude composed of mature adipose and haemopoietic tissue. secondary causes of hypertension, including serum They are very rare, with an incidence rate of between electrolytes, urinalysis and a chest radiograph were 0.08 to 0.20% at autopsy (1), and are usually normal.
    [Show full text]